Degree in Pharmaceutical Sciences from University of Heidelberg – PhD in Molecular Biology/Biochemistry from LMU in Munich – 20 years of experience in the Drug Development Industry.
Raphaela brings with her significant scientific expertise that allows her to be a reliable partner for business expansion of service providers in the drug development industry. In the last decade her job has included oversight of Marketing, Business Development and Client Services including Vendor Management for full and functional clinical research services for phases I to IV in main therapeutic areas and rare diseases; she has created partnerships with clinical CROs in Europe and globally and integrated complement services (e.g. drug supply, central lab, preclinical support).
She has many years of experience as a consultant to the German/Italian pharmaceutical industry. She regularly attends international conferences and training programs and keeps a close check on market trends and innovation in clinical development.
Oriented towards the latest trends in digitalization and real world data collection (real world evidence), she applies her knowledge about technology and regulatory aspects to create awareness among stakeholders in favour of patient-centric trials and provides industry partners with premium support in preclinical and clinical phase drug development.
Raphaela is part of the German and Italian associations of Pharmaceutical Medicine (DGPharMed, SIMeF) and since 2018 part of the scientific board of the annual event Patient Partnering in Clinical Development (PPCD). She successfully completed the educational activity from Drug Information Association (DIA) related to Patient Engagement in Drug Development.